Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer

0
0 / 5 (0 votos)

Oncology: International Journal of Cancer Research and Treatment

Fecha de publicación: March 2018

DOI: https://doi.org/10.1159/000485658

Autores: Lee S.J.,  Lee J.Kim W.W., Jung J.H., Park H.Y., Park J.-Y. Chae Y.S.

Background: A differential diagnostic role for plasma Del-1 was proposed for early breast cancer (EBC) in our previous study. We examined tumoral Del-1 expression and analyzed its prognostic impact among patients with EBC. 

SEGUIR LEYENDO